BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Mike Grey will be moderating a panel discussion on strategies for CNS drug and device development at the Neurotech Investing and Partnering Conference in San Francisco, CA.
News | 05. 10. 2011
